ShareValue.ai

ShareValue scores for AGARWALEYE.NSE: Valuation 29, Quality 45, Growth 62, Health 49.

AGARWALEYE.NSE
NSE

AGARWALEYE

₹439.40(-2.14%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 10%
Valuation
29
Overvalued
Price vs Value
Quality
45
Moderate
Business Strength
Growth
62
Moderate
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
60
Bullish
Price Trend

Company Details

About

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.

Score Analysis

AI Investment Thesis

Data as of:Jun 12, 2026
|
Last calculated:Jun 12, 2026